MJBizDaily Acquires The Emerald Conference
Marijuana Business Daily (MJBiz Daily), a media and events company that produces the world's largest cannabis business trade show (MJBizCon), announced the acquisition of Emerald Scientific's The Emerald Conference.
Marijuana Business Daily (MJBiz Daily), a media and events company that produces the world's largest cannabis business trade show (MJBizCon), announced the acquisition of Emerald Scientific's The Emerald Conference, a technical and comprehensive science conference in the cannabis industry (1).
"We believe science needs to be the backbone of the cannabis sector and that it will become a much bigger part of the industry, from the business side to regulations to healthcare to the international landscape. This acquisition ensures we will play a leading role in making that happen and fostering growth," said Chris Walsh, CEO of MJBizDaily, in a press release (1). "The Emerald Conference has become the go-to event for scientists, related businesses, researchers and healthcare professionals. We will now take it to next level."
According the announcement, MJBizDaily plans to expand and enhance the conference, boost education and networking opportunities, and drive science and research forward. The company will reportedly bolster its reach in the science community in other ways as well, leveraging its digital publishing assets, event portfolio, and additional resources to provide content, knowledge sharing, networking opportunities, and information on the latest research via a variety of formats and mediums.
Under the terms of the deal, Emerald Scientific will reportedly consult with MJBizDaily on science content and events as part of a multiyear partnership. It also will continue to have a prominent presence at The Emerald Conference and other science-related events that MJBizDaily produces.
"This is more than an acquisition-it's a strategic partnership that allows us to incorporate Emerald Scientific's thought leadership and market insights," Walsh said.
References:
Ep 24, Part I: Data Transparency in Cannabis Testing with Yasha Khan
November 21st 2024Evan Friedmann interviews Yasha Khan, co-founder of MCR Labs, about his journey into the cannabis industry and his efforts to promote transparency and integrity in laboratory practices. Yasha discusses the origins of MCR Labs, which began in Massachusetts to meet the needs of the soon-to-be legal medical cannabis market. He explains the challenges faced, including result manipulation by labs and the impact on public health. Yasha's Freedom of Information Act (FOIA) project aimed to gather testing data from 37 states, revealed significant discrepancies in potency and mold results. Despite some states' reluctance to share data, Yasha has made much of this data public, leading to collaborative research and publications on various aspects of cannabis testing.
Assessing Cannabis as a Harm Reduction Strategy: Insights from a Large-Scale Study
November 19th 2024A New Zealand study aimed to assess cannabis use as a harm reduction tool. Findings highlight lifestyle factors, and suggest cannabis-focused harm reduction strategies in reducing other substance use such as alcohol.
Ep 23, Part III: Accreditation in the Cannabis Industry with Susan Audino
October 24th 2024In Part III of this episode, host Evan Friedmann is joined by Susan Audino, PhD, founder of S.A. Audino & Associates, LLC, and co-founder of Saturn Scientific, LLC, to examine the complexities of sampling in the cannabis industry, emphasizing the need for proper sampling plans, and methods.
